Assignee
BIOLEX THERAPEUTICS INC
US·12 granted patents·8 pending applications·81 citations·filing 2002–2010
Top patents by PatentIndex Score
20 records- 0192US7884264B2Compositions and methods for inhibition of fucosyltransferase and xylosyltransferase expression in duckweed plantsBIOLEX THERAPEUTICS INC·Filed 2007·Granted Feb 8, 2011·26 cites·86 claims
- 0287US8022270B2Expression of biologically active polypeptides in duckweedBIOLEX THERAPEUTICS INC·Filed 2003·Granted Sep 20, 2011·21 cites·11 claims
- 0387US7632983B2Expression of monoclonal antibodies in duckweedBIOLEX THERAPEUTICS INC·Filed 2004·Granted Dec 15, 2009·21 cites·9 claims
- 0477US8034916B2Expression control elements from the Lemnaceae familyBIOLEX THERAPEUTICS INC·Filed 2009·Granted Oct 11, 2011·5 cites·23 claims
- 0573US7867518B2Controlled release compositions for interferon based on PEGT/PBT block copolymers and method for preparation thereofBIOLEX THERAPEUTICS INC·Filed 2009·Granted Jan 11, 2011·2 cites·22 claims
- 0673US7736674B2Controlled release compositions for interferon based on PEGT/PBT block copolymersBIOLEX THERAPEUTICS INC·Filed 2007·Granted Jun 15, 2010·2 cites·27 claims
- 0763US7326385B2Plate and method for high throughput screeningBIOLEX THERAPEUTICS INC·Filed 2002·Granted Feb 5, 2008·4 cites·15 claims
- 0861US7915483B2C-terminally truncated interferonBIOLEX THERAPEUTICS INC·Filed 2007·Granted Mar 29, 2011·0 cites·11 claims
- 0961US2008096269A1Plate and method for high throughput screeningBIOLEX THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 1059US2008096270A1Plate and method for high throughput screeningBIOLEX THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 1159US2008096272A1Plate and method for high throughput screeningBIOLEX THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 1259US2008102518A1Plate and method for high throughput screeningBIOLEX THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 1356US8017836B2Expression of plasminogen and microplasminogen in duckweedBIOLEX THERAPEUTICS INC·Filed 2009·Granted Sep 13, 2011·0 cites·18 claims
- 1454US7959910B2C-terminally truncated interferon alpha variantsBIOLEX THERAPEUTICS INC·Filed 2004·Granted Jun 14, 2011·0 cites·10 claims
- 1549US2009060921A1Glycan-optimized anti-cd20 antibodiesBIOLEX THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 1649US2008098585A1Plate and method for high throughput screeningBIOLEX THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 1748US2011144308A1Compositions and methods for humanization and optimization of n-glycans in plantsBIOLEX THERAPEUTICS INC·Filed 2010·Application pending·0 cites
- 1845US7659445B2Expression of plasminogen and microplasminogen in duck weedBIOLEX THERAPEUTICS INC·Filed 2005·Granted Feb 9, 2010·0 cites·16 claims
- 1944US2010209966A1Aseptic bioreactor system for processing biological materialsBIOLEX THERAPEUTICS INC·Filed 2010·Application pending·0 cites
- 2036US7709699B2Use of duckweed in high throughput screeningBIOLEX THERAPEUTICS INC·Filed 2002·Granted May 4, 2010·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when BIOLEX THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →